Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis

Condition:   Psoriasis Vulgaris Interventions:   Drug: 0.01% Halobetasol;   Drug: 0.045% Tazarotene;   Drug: 0.05% Clobetasol Propionate Sponsor:   Dermatology Consulting Services, PLLC Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials